OptimizeRx Continues COVID-19 Webinar Series, Addressing the Rapid Adoption of Telehealth
This will be the sixth in a series of webinars
The panel will be moderated by
Topic: Learning Together—The Rapid Adoption of Telehealth During COVID-19. Will it Stick? In the face of social distancing to prevent further spread of the coronavirus, telehealth has emerged as the safest and most viable way to ensure patients have access to medical consults and care.
While telehealth is not new, it is suddenly experiencing unprecedented demand and easing of regulations because of the coronavirus crisis. Will this lead to a more permanent use of telehealth? Will broader telehealth initiatives persist after the pandemic subsides? The discussion will address the intricacies and opportunities of this extraordinary moment for telehealth, the growing importance of virtual care and its place in telehealth, and what these changes mean for the healthcare industry as a whole.
The webinar is open and free to anyone interested in participating in a practical conversation with industry leaders.
Register today at www.optimizerx.com/webinars.
For more information about OptimizeRx’s webinar sessions, contact media relations at (754) 245-7070 or firstname.lastname@example.org.
The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.
Tel (248) 651-6568 x807
Media Relations Contact
Tel (754) 245-7070
Investor Relations Contact
Tel (949) 432-7557
Source: OptimizeRx Corporation